心脏CT与PET用于心脏移植受者监测:系统综述与贝叶斯Meta分析
该系统综述与贝叶斯Meta分析纳入44项研究(32项CT、12项PET)共3049例患者,评估心脏CT和PET诊断心脏移植血管病变(CAV)及预测主要不良心血管结局的能力。冠状动脉CTA检测任何CAV的敏感度97.6%、特异度82.3%,检测显著CAV的敏感度与特异度均为92.6%;PET CAV算法检测显著CAV的敏感度83.9%、特异度89.6%。作者结论认为两者均可排除显著CAV,但高验前概率时冠状动脉CTA可能更可取,多个PET参数可能有预后价值而CT长期预后证据不足。
要点
- 冠状动脉CTA排除任何CAV敏感度97.6%,排除显著CAV敏感度与特异度均为92.6%。
- PET CAV算法检测显著CAV敏感度83.9%、特异度89.6%。
- 高验前概率时冠状动脉CTA可能更可取,CT长期预后价值证据不足。
核心结论
- 冠状动脉CTA和PET均可排除显著CAV;在高验前概率时冠状动脉CTA可能更可取;多个PET衍生参数可能有预后价值,而CT长期预后价值证据不足。
研究设计与样本
- 系统综述与贝叶斯Meta分析,纳入44项研究(32项CT、12项PET)共3049例患者,评估CT或PET检测血管造影CAV的诊断价值及预测主要不良心血管结局的预后价值;敏感度与特异度采用贝叶斯双变量双正态随机效应模型合并,HR采用贝叶斯正态随机效应模型合并。
诊断标准与关键数值
- 冠状动脉CTA检测任何CAV:敏感度97.6%(95%CrI 93.7%-99.1%),特异度82.3%(95%CrI 75.3%-88.3%)。
- 冠状动脉CTA检测显著CAV:敏感度92.6%(95%CrI 86.2%-96.2%),特异度92.6%(95%CrI 89.8%-94.9%)。
- PET CAV算法检测显著CAV:敏感度83.9%(95%CrI 69.1%-92.4%),特异度89.6%(95%CrI 82.2%-94.2%)。
临床应用与阅片要点
- 2023年ISHLT指南对心脏CT和PET用于CAV无创监测给予Class IIa推荐,但实施滞后于推荐。
- 冠状动脉CTA和PET均可用于排除显著CAV;在高验前概率时冠状动脉CTA可能更可取。
- 多个PET衍生参数(心肌血流储备、负荷心肌血流量、PET CAV评分、负荷总评分)可预测未来主要不良心血管结局。
- CT长期预后价值证据不足。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: For noninvasive surveillance of cardiac allograft vasculopathy (CAV), cardiac computed tomography (cardiac computed tomography [CT]) and positron emission tomography (PET) received a Class IIa recommendation by the 2023 ISHLT (International Society for Heart and Lung Transplantation) guidelines. However, implementation has lagged behind because of concerns about their ability to rule out disease and stratify risk.
OBJECTIVES: The purpose of this study was to define the diagnostic and prognostic ability of PET and cardiac CT in cardiac transplant recipients.
METHODS: Electronic databases were searched for studies evaluating CT or PET for their diagnostic (for detecting angiographic CAV) and prognostic (for predicting major adverse cardiovascular outcomes) value. Sensitivity and specificity were pooled using Bayesian bivariate binormal-normal models with random-effects. HRs were pooled using Bayesian normal random-effects models.
RESULTS: In total, 44 studies (32 CT and 12 PET) enrolling 3,049 patients were included. Coronary computed tomography angiography (CTA) showed high sensitivity (97.6%; 95% credible interval [CrI]: 93.7%-99.1%) and specificity (82.3%; 95% CrI: 75.3%-88.3%) for detecting any CAV. Coronary CTA also showed high sensitivity (92.6%; 95% CrI: 86.2%-96.2%) and specificity (92.6%; 95% CrI: 89.8%-94.9%) for significant CAV. The PET CAV algorithm for detecting significant CAV showed good sensitivity (83.9%; 95% CrI: 69.1%-92.4%) and specificity (89.6%; 95% CrI: 82.2%-94.2%). PET-derived parameters including myocardial flow reserve, stress myocardial blood flow, PET CAV score, and summed stress score, predicted future major adverse cardiovascular outcomes.
CONCLUSIONS: Both coronary CTA and PET can rule out significant CAV; however, at higher pretest probabilities, coronary CTA may be preferrable. Multiple PET-derived parameters may have prognostic value, whereas there is insufficient evidence for the long-term prognostic value of CT.
引用
- Sayed A, Nayfeh M, Alahdab F, et al. Cardiac CT and PET for Surveillance of Heart Transplant Recipients: Systematic Review and Bayesian Meta-Analysis. JACC Cardiovasc Imaging. 2025. PMID: 40742356. doi:10.1016/j.jcmg.2025.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。